A promising TB vaccine can be protected from heat damage with a technique developed at the University of Bath.
Scientists working on a new tuberculosis (TB) vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a technique developed at the University of Bath.
Their method prevents these crucial vaccine components from spoiling outside of a fridge – meaning a thermally stable vaccine that can be reliably delivered to remote areas around the world is more likely.
There is an urgent need not only for a new TB vaccine, but also for methods to keep vaccines stable outside of the refrigeration ‘cold chain’ – as up to 50% of vaccine doses are discarded before use due to exposure to suboptimal temperatures. Thermostable vaccines have therefore been named a priority research area in the World Health Organisation’s Global Vaccine Action Plan 2011-2020.
Ensilication, a method developed at the University of Bath, “shrink-wraps” vaccine proteins in position using layers of silica that build up into a cage around the molecules – so they don’t unravel when exposed to temperatures that would usually break them down. The proteins are held in place until ready to be removed from the silica cage and delivered.
The research team from the Departments of Biology & Biochemistry and Chemistry first demonstrated that the TB antigen ag85b and a vaccine fused with the adjuvant protein Sbi are sensitive to breaking down outside of refrigerated temperatures. They then showed that these vaccine components were protected from heat damage when ensilicated and kept on a shelf at room temperature for long periods of time without loss of structure and function.
This is first time that ensilication has been used to improve the thermal stability of proteins in a vaccine setting, after proof-of-principle work using model proteins.
The results are a big step forward not only in developing a thermally-stable TB vaccines, but in showing that ensilication could be used for many different kinds of vaccines.
The study is published in Scientific Reports
Lead author Professor Jean van den Elsen, said: “A new TB vaccine is really urgently needed to supplement or replace the existing BCG vaccine and reduce the number of TB cases and deaths – particularly as drug-resistant TB infections remain high.”
First author Ayla Wahid, added: “To make the vaccine as effective as possible it needs to be thermally-stable, or in other words not spoil outside of a fridge, which is why we’re really encouraged by these results. Cold-chain storage leads to a lot of wastage and expense which could be avoided by ensilication.”
Dr Asel Sartbaeva, who invented ensilication, added: “Our results reveal the potential of ensilication in storing and transporting life-saving vaccines at ambient temperatures globally – in particular to remote areas of developing countries where disease rates are often highest.
“With up to 50% of vaccines being thrown away, and refrigeration raising vaccine costs by up to 80%, this is a major global health challenge that we need to overcome. By demonstrating for the first time that ensilication works to protect vaccine-relevant proteins from breaking down outside a fridge we’re a big step closer to achieving this goal.”
The Latest on: TB vaccine
via Google News
The Latest on: TB vaccine
- Stephen L. Carter: COVID vaccine wins make big pharma look heroicon April 19, 2021 at 6:09 pm
Amidst the national euphoria over the COVID-19 vaccines, it’s hard to believe that just two years ago, Big Pharma was essentially hated. In a 2019 survey, Gallup found that the public had ...
- Science and need — not wealth or nationality — should guide vaccine allocation and prioritizationon April 19, 2021 at 12:44 pm
Ensuring COVID-19 vaccine access for refugee and displaced populations, and addressing health inequities, is vital for an effective pandemic ...
- 10 next-gen Covid-19 vaccines in the race for approvalon April 19, 2021 at 9:55 am
With dozens of new Covid-19 vaccines in various stages of development, Clinical Trials Arena tracks the race to approval between those closest to the finish line. To aid in the fight against the ...
- Why self-amplifying RNA vaccines are ‘revolutionary’on April 19, 2021 at 4:29 am
Once injected, the self-amplifying RNA produces copies of itself inside muscle cells, making lots of spike proteins. The recipient’s immune system then identifies these spikes on the surface of muscle ...
- All Virginians 16 and older now eligible for COVID-19 vaccineon April 19, 2021 at 3:31 am
This morning, the Virginia Department of Health will be issuing a message alerting everyone 16+ they are now eligible to register for the shot under Phase 2.
- Ensure Adequate Supply Of Covid Vaccines, Oxygen: Mayawati To Centreon April 19, 2021 at 1:07 am
BSP chief Mayawati on Monday urged the Centre to ensure adequate supply of coronavirus vaccines and medical oxygen and if needed import these from other countries to combat the crisis created by the ...
- Valo Therapeutics Acquires University of Helsinki's PeptiBAC Cancer and Infectious Disease Vaccination Technologyon April 19, 2021 at 12:27 am
Valo Therapeutics Limited (Valo Tx), the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases, today announced the acquisition of intellectual property rights for ...
- University of Helsinki sold cancer and infectious disease vaccination platform called PeptiBAC to Valo Therapeuticson April 18, 2021 at 11:02 pm
Potential for regional tuberculosis vaccines, novel personalized cancer vaccines, and improving checkpoint inhibition therapy University ...
- China is starting clinical trials of a Covid vaccine that can be inhaledon April 18, 2021 at 10:13 pm
CEO of CanSino Biologics, Xuefeng Yu, said a vaccine that's inhaled could be more effective than those injected.
- Volunteers to be reinfected with Covid-19 to help improve vaccineson April 18, 2021 at 9:22 pm
Volunteers who have recovered from a coronavirus infection will be deliberately infected with the virus for a second time, in a new study which could help develop new treatments and vaccines against ...
via Bing News